Analysis of siRNA Drugs at Denaturing UPLC Conditions Using MaxPeak Premier Column Technology

Library Number:
APNT135088513
Part Number:
720007362EN
Author(s):
Irene Suarez Marina, Willy Verluyten, Evelien Dejaegere, Leslie Napoletano, J-P Boon, Mario Hellings, Martin Gilar
Source:
Janssen Pharmaceutical Companies of Johnson & Johnson, Waters Corporation
Content Type:
Application Notes
Content Subtype:
Application Notes
Related Products:
 
 
 
 

This application note demonstrates the utility of ACQUITY Premier Peptide BEH C18, 300 Å Column for analysis of small interfering RNA (siRNA) therapeutic candidate compound. 


Title Format File Size
Download PDF PDF 718.91kB